Osarogiagbon RU - Search Results

1

Institutional-Level Differences in Quality and Outcomes of Lung Cancer Resections in the United States.

Osarogiagbon RU, Sineshaw HM, Lin CC, Jemal A. Osarogiagbon RU, et al. Chest. 2021 Apr;159(4):1630-1641. doi: 10.1016/j.chest.2020.10.075. Epub 2020 Nov 14. Chest. 2021. PMID: 33197400 Free PMC article.

2

Outcome of surgical resection for pathologic N0 and Nx non-small cell lung cancer.

Osarogiagbon RU, Allen JW, Farooq A, Berry A, Spencer D, O'Brien T. Osarogiagbon RU, et al. J Thorac Oncol. 2010 Feb;5(2):191-6. doi: 10.1097/JTO.0b013e3181c8cc32. J Thorac Oncol. 2010. PMID: 20035237 Free article.

3

Quality of surgical resection for nonsmall cell lung cancer in a US metropolitan area.

Allen JW, Farooq A, O'Brien TF, Osarogiagbon RU. Allen JW, et al. Among authors: osarogiagbon ru. Cancer. 2011 Jan 1;117(1):134-42. doi: 10.1002/cncr.25334. Epub 2010 Aug 24. Cancer. 2011. PMID: 20737568 Free article.

4

Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.

Osarogiagbon RU, Allen JW, Farooq A, Berry A, O'Brien T. Osarogiagbon RU, et al. Ann Thorac Surg. 2011 May;91(5):1486-92. doi: 10.1016/j.athoracsur.2010.11.065. Ann Thorac Surg. 2011. PMID: 21524460

5

Use of a surgical specimen-collection kit to improve mediastinal lymph-node examination of resectable lung cancer.

Osarogiagbon RU, Miller LE, Ramirez RA, Wang CG, O'Brien TF, Yu X, Khandekar A, Schoettle GP, Robbins SG, Robbins ET, Gibson JB. Osarogiagbon RU, et al. J Thorac Oncol. 2012 Aug;7(8):1276-82. doi: 10.1097/JTO.0b013e318257fbe5. J Thorac Oncol. 2012. PMID: 22653076 Free article.

6

Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.

Osarogiagbon RU, Yu X. Osarogiagbon RU, et al. J Thorac Oncol. 2012 Dec;7(12):1798-1806. doi: 10.1097/JTO.0b013e31827457db. J Thorac Oncol. 2012. PMID: 23154551 Free article.

7

Nonexamination of lymph nodes and survival after resection of non-small cell lung cancer.

Osarogiagbon RU, Yu X. Osarogiagbon RU, et al. Ann Thorac Surg. 2013 Oct;96(4):1178-1189. doi: 10.1016/j.athoracsur.2013.05.021. Epub 2013 Jul 30. Ann Thorac Surg. 2013. PMID: 23910633

8

Dual intervention to improve pathologic staging of resectable lung cancer.

Osarogiagbon RU, Ramirez RA, Wang CG, Miller LE, Smeltzer MM, Sareen S, Javed AY, Robbins SG, Khandekar A, Wolf BA, Gibson J, Spencer D, Robbins ET. Osarogiagbon RU, et al. Ann Thorac Surg. 2013 Dec;96(6):1975-81. doi: 10.1016/j.athoracsur.2013.07.009. Epub 2013 Sep 23. Ann Thorac Surg. 2013. PMID: 24067333

9

Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer.

Osarogiagbon RU, Ogbata O, Yu X. Osarogiagbon RU, et al. Ann Thorac Surg. 2014 Feb;97(2):385-93. doi: 10.1016/j.athoracsur.2013.09.058. Epub 2013 Nov 20. Ann Thorac Surg. 2014. PMID: 24266949 Free PMC article.

10

The impact of a novel lung gross dissection protocol on intrapulmonary lymph node retrieval from lung cancer resection specimens.

Osarogiagbon RU, Eke R, Sareen S, Leary C, Coleman L, Faris N, Yu X, Spencer D. Osarogiagbon RU, et al. Ann Diagn Pathol. 2014 Aug;18(4):220-6. doi: 10.1016/j.anndiagpath.2014.03.005. Epub 2014 Apr 26. Ann Diagn Pathol. 2014. PMID: 24866232 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters